In a world where breast cancer still claims too many lives too late, Gabbi isn't just building a tool—they're building a safety net. By partnering directly with health systems and employers, they're turning risk assessment into actionable, immediate care.

"Their mission isn't just to detect cancer—it's to eradicate late-stage breast cancer entirely."

The absence of traditional funding data is telling. At $8.4M in revenue, Gabbi likely operates on a profitable, bootstrapped, or revenue-backed model. They aren't burning cash to acquire users—they're selling a proven solution to institutions that pay for outcomes, not clicks.

• B2B2C Model: Sells directly to health systems and employers, not patients.
• High Revenue per Employee: ~$215k revenue/employee indicates a lean, efficient operation.
• Tech-Enabled Care: Uses Gatsby and Prismic for a dynamic, compliant patient interface.